Showing results (121-130 of 170) with videos related to
Sort By:
Pageof 17
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2014
Incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitantJordan D Lundberg, Brooke Sorgen Crawford, Gary Phillips, et al.Acta Anaesthesiologica Scandinavica|April 1, 1985
Intestinal vascular effects of inhaled and locally administered enflurane in the catB A Henriksson, B Biber, D Lundberg, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 23, 2020
Antiemetic medication efficacy during EPOCH and R-EPOCH treatmentMegan K Fleming, Allison Carr, Junan Li, et al.Acta Anaesthesiologica Scandinavica|January 1, 1987
Propofol vs thiopentone as anaesthetic agents for short operative proceduresB A Henriksson, P Carlsson, B Hallén, et al.Acta Anaesthesiologica Scandinavica. Supplementum|January 1, 1982
Beta-receptor blockade and spinal anaesthesia. Withdrawal versus continuation of long-term therapyJ Pontén, B Biber, T Bjurö, et al.Acta Chirurgica Scandinavica|March 1, 1987
Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441)H Högström, G Claeson, C Larsson-Backström, et al.Blood|March 15, 1990
Membrane expression of platelet calpainA H Schmaier, H N Bradford, D Lundberg, et al.Resuscitation Plus|December 13, 2021
Outcomes and interventions in patients transported to hospital with ongoing CPR after out-of-hospital cardiac arrest - An observational studyS Schmidbauer, E J Yates, C Andréll, et al.Neurology|July 22, 2011
Neuron-specific enolase correlates with other prognostic markers after cardiac arrestT Cronberg, M Rundgren, E Westhall, et al.Diabetes, Obesity & Metabolism|February 14, 2008
Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetesM R Clements, J Tits, B T Kinsley, et al.Pageof 17